Mediclinic International PLC (LON:MDC) has received a consensus recommendation of “Hold” from the nine brokerages that are covering the firm, Marketbeat reports. Two investment analysts have rated the stock with a sell rating and seven have given a hold rating to the company. The average 1-year price objective among analysts that have issued a report on the stock in the last year is GBX 801.25 ($10.57).

Several brokerages have recently weighed in on MDC. Credit Suisse Group reiterated a “neutral” rating on shares of Mediclinic International PLC in a research report on Friday, July 21st. Citigroup Inc. reiterated a “neutral” rating and set a GBX 790 ($10.42) target price on shares of Mediclinic International PLC in a research report on Tuesday, June 27th. HSBC Holdings plc lifted their target price on shares of Mediclinic International PLC from GBX 640 ($8.44) to GBX 660 ($8.71) and gave the company a “reduce” rating in a research report on Tuesday, April 18th. Investec lowered shares of Mediclinic International PLC to a “hold” rating and set a GBX 775 ($10.22) target price on the stock. in a research report on Monday, June 26th. Finally, Jefferies Group LLC lifted their target price on shares of Mediclinic International PLC from GBX 646 ($8.52) to GBX 650 ($8.57) and gave the company an “underperform” rating in a research report on Thursday, June 1st.

TRADEMARK VIOLATION NOTICE: “Mediclinic International PLC (MDC) Given Average Rating of “Hold” by Brokerages” was posted by American Banking News and is the property of of American Banking News. If you are accessing this news story on another domain, it was copied illegally and republished in violation of U.S. and international copyright & trademark legislation. The correct version of this news story can be accessed at https://www.americanbankingnews.com/2017/08/04/mediclinic-international-plc-mdc-given-average-rating-of-hold-by-brokerages.html.

Shares of Mediclinic International PLC (LON:MDC) traded up 4.06% during trading on Friday, reaching GBX 756.00. 1,784,124 shares of the company’s stock were exchanged. Mediclinic International PLC has a 52-week low of GBX 666.50 and a 52-week high of GBX 1,124.00. The company’s market capitalization is GBX 5.57 billion. The company has a 50 day moving average price of GBX 751.38 and a 200-day moving average price of GBX 774.07.

The company also recently declared a dividend, which was paid on Monday, July 31st. Shareholders of record on Thursday, June 22nd were given a GBX 4.70 ($0.06) dividend. The ex-dividend date was Thursday, June 22nd. This is a positive change from Mediclinic International PLC’s previous dividend of $3.20. This represents a yield of 0.58%.

About Mediclinic International PLC

Mediclinic International plc is an international private healthcare provider. The Company’s segments include Mediclinic Southern Africa, Mediclinic Switzerland, Mediclinic Middle East, United Kingdom and Corporate. It focuses on providing acute care and multidisciplinary healthcare services. It has interest in Spire Healthcare, a United Kingdom-based private healthcare company.

Analyst Recommendations for Mediclinic International PLC (LON:MDC)

Receive News & Ratings for Mediclinic International PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mediclinic International PLC and related companies with MarketBeat.com's FREE daily email newsletter.